In glioma tissue sections, it was observed that the expression levels of IDO1, VEGFA, and CD34 were positively correlated with the pathological grades, with expression levels in grade III/IV glioma patients significantly higher than in patients of lower grade (Figure 1A). This evidence concerns the gene IDO1 and central nervous system cancer.